financial post
Ventus Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating VENT-02, an Oral, Brain-Penetrant NLRP3 Inhibitor, in Parkinson’s Disease
Financial Post • 3 MONTHS AGO
Esri Collaborates with Google Maps Platform to Offer High-Quality Photorealistic 3D Tiles
Financial Post • 3 MONTHS AGO
Augurex Announces UK Conformity Assessed (UKCA) Authorization for JOINTstat®, Expanding Access to Cutting-Edge Rheumatoid Arthritis Testing in Great Britain
Financial Post • 3 MONTHS AGO
New KnowBe4 Report Reveals Stolen Credentials Emerge as Top Concern in Global Retail Sector
Financial Post • 3 MONTHS AGO
Kymeta Goshawk™ u8 Enters Global Market as European Allies Face Growing Defense Pressures
Financial Post • 3 MONTHS AGO
Germany’s prospective new government struggles to win support for defense, infrastructure plans
Financial Post • 3 MONTHS AGO
Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf as Certain Class Actions Move Forward
Financial Post • 3 MONTHS AGO
City of Brampton selects Genetec solutions to enhance public safety and combat vehicle theft
Financial Post • 3 MONTHS AGO